KR20040048381A - 신규 갈락토실세라미드 유사체, 이를 사용한β-글루코세레브로시다제 활성화제, 피부 외용제 및β-글루코세레브로시다제 활성화 방법 - Google Patents
신규 갈락토실세라미드 유사체, 이를 사용한β-글루코세레브로시다제 활성화제, 피부 외용제 및β-글루코세레브로시다제 활성화 방법 Download PDFInfo
- Publication number
- KR20040048381A KR20040048381A KR10-2003-7016943A KR20037016943A KR20040048381A KR 20040048381 A KR20040048381 A KR 20040048381A KR 20037016943 A KR20037016943 A KR 20037016943A KR 20040048381 A KR20040048381 A KR 20040048381A
- Authority
- KR
- South Korea
- Prior art keywords
- glucocerebrosidase
- formula
- skin
- activating
- galactosylceramide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (15)
- 하기 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체.<화학식 1><화학식 2>상기 식에서,X 및 Y는 S 또는 0이고,R1및 R2는 탄소수 9 내지 35의 알킬기 또는 알케닐기이며,R3은 탄소수 2 내지 30의 알킬기 또는 알케닐기이다.
- 하기 화학식 3으로 표시되는 갈락토실세라미드 유사체.<화학식 3>
- 하기 화학식 4로 표시되는 갈락토실세라미드 유사체.<화학식 4>
- 하기 화학식 5로 표시되는 갈락토실세라미드 유사체.<화학식 5>
- 하기 화학식 6으로 표시되는 갈락토실세라미드 유사체.<화학식 6>
- 제1항에 기재된 갈락토실세라미드 유사체를 함유하는 것을 특징으로 하는 피부 외용제.
- 제1항에 기재된 갈락토실세라미드 유사체를 유효 성분으로 하는 β-글루코세레브로시다제 활성화제.
- 제6항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 0.005 내지 5.0 질량% 함유하는 피부 외용제.
- 제6항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 0.01 내지 3.0 질량% 함유하는 피부 외용제.
- 제7항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 0.005 내지 5.0 질량% 함유하는 β-글루코세레브로시다제 활성화제.
- 제7항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를0.01 내지 3.0 질량% 함유하는 β-글루코세레브로시다제 활성화제.
- 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 피부에 적용하여, β-글루코세레브로시다제를 활성화하는 것을 특징으로 하는 β-글루코세레브로시다제 활성화 방법.
- 제12항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 0.005 내지 5.0 질량% 함유하는 조성물을 사용하는 것을 특징으로 하는 β-글루코세레브로시다제 활성화 방법.
- 제12항에 있어서, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 0.01 내지 3.0 질량% 함유하는 조성물을 사용하는 것을 특징으로 하는 β-글루코세레브로시다제 활성화 방법.
- β-글루코세레브로시다제를 활성화시킴으로써 피부의 거칠음을 개선하는 방법으로, 화학식 1 또는 2로 표시되는 갈락토실세라미드 유사체를 피부에 적용하는 것을 특징으로 하는 거친 피부 개선 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2001-00196016 | 2001-06-28 | ||
JP2001196016A JP4070966B2 (ja) | 2001-06-28 | 2001-06-28 | 新規ガラクトシルセラミド類縁体及び用途 |
PCT/JP2002/006532 WO2003002584A1 (fr) | 2001-06-28 | 2002-06-27 | Nouveaux analogues de galactosylceramide et activateurs de $g(b)-glucocerebrosidase, preparations externes pour la peau et procede d'activation de $g(b)-glucocerebrosidase au moyen d'analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040048381A true KR20040048381A (ko) | 2004-06-09 |
KR100739250B1 KR100739250B1 (ko) | 2007-07-12 |
Family
ID=19033898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037016943A KR100739250B1 (ko) | 2001-06-28 | 2002-06-27 | 신규 갈락토실세라미드 유사체, 이를 사용한β-글루코세레브로시다제 활성화제, 피부 외용제 및β-글루코세레브로시다제 활성화 방법 |
Country Status (9)
Country | Link |
---|---|
US (2) | US7183261B2 (ko) |
EP (1) | EP1408045B1 (ko) |
JP (1) | JP4070966B2 (ko) |
KR (1) | KR100739250B1 (ko) |
CN (1) | CN1247605C (ko) |
DE (1) | DE60232449D1 (ko) |
HK (1) | HK1067642A1 (ko) |
TW (2) | TWI322151B (ko) |
WO (1) | WO2003002584A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130054029A (ko) * | 2011-11-16 | 2013-05-24 | (주)아모레퍼시픽 | 글리코실 세라마이드 유사 화합물, 이의 제조방법 및 이를 함유하는 화장료 조성물 |
KR101589633B1 (ko) * | 2014-09-18 | 2016-02-01 | 한국과학기술연구원 | 당세라마이드 유도체 및 이의 제조방법 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5918168B2 (ja) * | 2012-04-27 | 2016-05-18 | 富士フイルム株式会社 | β−グルコセレブロシダーゼ活性増強剤 |
WO2014053482A1 (en) | 2012-10-03 | 2014-04-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists |
ES2958391T3 (es) | 2014-11-06 | 2024-02-08 | Bial R&D Invest S A | Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos |
EP3215509B1 (en) * | 2014-11-06 | 2020-02-26 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
WO2016073895A1 (en) | 2014-11-06 | 2016-05-12 | Lysosomal Therapeutics Inc. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
WO2017027848A1 (en) * | 2015-08-12 | 2017-02-16 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier |
WO2017040885A1 (en) | 2015-09-03 | 2017-03-09 | The Board Of Regents Of The University Of Oklahoma | Peptide inhibitors of clostridium difficile tcdb toxin |
EP3440080A4 (en) | 2016-04-06 | 2020-01-22 | Lysosomal Therapeutics Inc. | PYRAZOLO [1,5-A] PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
JP7034935B2 (ja) | 2016-04-06 | 2022-03-14 | リソソーマル・セラピューティクス・インコーポレイテッド | ピロロ[1,2-a]ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用 |
EP3440083A4 (en) | 2016-04-06 | 2019-09-18 | Lysosomal Therapeutics Inc. | IMIDAZO [1,5-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER |
KR102530515B1 (ko) | 2016-05-05 | 2023-05-09 | 비알 - 알&디 인베스트먼츠, 에스.에이. | 치환된 이미다조[1,2-b]피리다진, 치환된 이미다조[1,5-b]피리다진, 관련 화합물, 및 의학적 장애의 치료에서의 그의 용도 |
EP3452455A4 (en) | 2016-05-05 | 2019-11-13 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMDAZO [1,2-] PYRIDINES, SUBSTITUTED IMIDAZO [1,2-] PYRAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF ILLNESSES |
WO2017207040A1 (en) | 2016-06-01 | 2017-12-07 | Vib Vzw | ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR |
US10933126B2 (en) | 2018-05-03 | 2021-03-02 | The Board Of Regents Of The University Of Oklahoma | Clostridium difficile immunogenic compositions and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07110872B2 (ja) * | 1990-09-25 | 1995-11-29 | 株式会社ディ・ディ・エス研究所 | 酸性糖脂質及び微粒子キャリヤー |
JP2774417B2 (ja) | 1991-08-07 | 1998-07-09 | 株式会社ディ・ディ・エス研究所 | ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー |
IT1271624B (it) | 1994-03-21 | 1997-06-04 | Lifegroup Spa | Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita' |
JP2896321B2 (ja) * | 1994-10-27 | 1999-05-31 | 鐘紡株式会社 | β−グルコセレブロシダーゼの活性化方法 |
-
2001
- 2001-06-28 JP JP2001196016A patent/JP4070966B2/ja not_active Expired - Lifetime
-
2002
- 2002-06-27 KR KR1020037016943A patent/KR100739250B1/ko active IP Right Grant
- 2002-06-27 WO PCT/JP2002/006532 patent/WO2003002584A1/ja active Application Filing
- 2002-06-27 TW TW091114141A patent/TWI322151B/zh not_active IP Right Cessation
- 2002-06-27 US US10/482,110 patent/US7183261B2/en not_active Expired - Lifetime
- 2002-06-27 CN CNB028131487A patent/CN1247605C/zh not_active Expired - Lifetime
- 2002-06-27 TW TW098132688A patent/TW201002734A/zh unknown
- 2002-06-27 EP EP02743752A patent/EP1408045B1/en not_active Expired - Lifetime
- 2002-06-27 DE DE60232449T patent/DE60232449D1/de not_active Expired - Lifetime
-
2005
- 2005-01-28 HK HK05100756A patent/HK1067642A1/xx not_active IP Right Cessation
-
2007
- 2007-01-11 US US11/651,978 patent/US20070111951A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130054029A (ko) * | 2011-11-16 | 2013-05-24 | (주)아모레퍼시픽 | 글리코실 세라마이드 유사 화합물, 이의 제조방법 및 이를 함유하는 화장료 조성물 |
KR101589633B1 (ko) * | 2014-09-18 | 2016-02-01 | 한국과학기술연구원 | 당세라마이드 유도체 및 이의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
WO2003002584A1 (fr) | 2003-01-09 |
JP2003012684A (ja) | 2003-01-15 |
US7183261B2 (en) | 2007-02-27 |
EP1408045A4 (en) | 2005-12-28 |
US20040242499A1 (en) | 2004-12-02 |
EP1408045A1 (en) | 2004-04-14 |
TWI322151B (ko) | 2010-03-21 |
TW201002734A (en) | 2010-01-16 |
CN1522263A (zh) | 2004-08-18 |
HK1067642A1 (en) | 2005-04-15 |
DE60232449D1 (de) | 2009-07-09 |
EP1408045B1 (en) | 2009-05-27 |
KR100739250B1 (ko) | 2007-07-12 |
CN1247605C (zh) | 2006-03-29 |
US20070111951A1 (en) | 2007-05-17 |
JP4070966B2 (ja) | 2008-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100739250B1 (ko) | 신규 갈락토실세라미드 유사체, 이를 사용한β-글루코세레브로시다제 활성화제, 피부 외용제 및β-글루코세레브로시다제 활성화 방법 | |
KR101988675B1 (ko) | 피부 및/또는 점막의 치료 및/또는 관리에 유용한 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도 | |
US6323219B1 (en) | Methods for treating immunomediated inflammatory disorders | |
KR101073303B1 (ko) | 안정한 비타민 b6 유도체 | |
US5607968A (en) | Topical alkyl-2-O-L-ascorbyl-phosphates | |
MX2010009485A (es) | Composiciones farmaceuticas o cosmeticas que comprenden inhibidores de metaloproteinasa. | |
EP0875514A1 (en) | Ascorbic acid derivative and vitamin C preparation containing the same | |
JP6830580B2 (ja) | セラミド含量増加剤 | |
JP2006290873A (ja) | アクアポリン発現促進剤 | |
CN110475474B (zh) | 化合物和使用方法 | |
WO2006106992A1 (ja) | メラニン生成抑制剤 | |
JP2001302690A (ja) | 皮膚浸透性トリペプチド、皮膚浸透性コラーゲンペプチド、皮膚浸透性外用剤および高吸収性食品 | |
JP4589865B2 (ja) | N−アセチルグルコサミン誘導体、及びその用途 | |
AU2015345943B2 (en) | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration | |
US7045546B2 (en) | Stabilized derivatives of ascorbic acid-3-phosphate | |
JP2002128702A (ja) | 局所活性成分の効力のモノ−アシル−(リゾ)−グリセロリン脂質による増強方法およびその用途 | |
JP4266081B2 (ja) | 新規スフィンゴミエリン及び皮膚外用剤 | |
JP4307784B2 (ja) | グリコシル−l−アスコルビン酸のアシル化誘導体及びその用途 | |
EP4180418A1 (en) | Novel sphingolipid containing branched-chain fatty acid and use thereof | |
JP2009203192A (ja) | インボルクリン産生促進剤、及び肌荒れ防止又は改善用皮膚外用剤 | |
JP3645082B2 (ja) | セラミド合成促進剤 | |
WO2010021034A1 (ja) | 皮膚外用剤 | |
US9562065B2 (en) | Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical cosmetic uses of same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130621 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140626 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150626 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160628 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170623 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 12 |